Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » PCR » High-Resolution Melting Analysis May Be Cost-Effective to Evaluate Recurrent Pregnancy Loss

High-Resolution Melting Analysis May Be Cost-Effective to Evaluate Recurrent Pregnancy Loss

Apr 10, 2020
|
John Gilmore
Premium

NEW YORK – Researchers in China have adapted high-resolution melting analysis (HRM) to evaluate chromosomal abnormalities that are linked to recurrent pregnancy loss (RPL) in patients.

The team believes that clinicians could eventually use the method to improve the cost-effectiveness of RPL examinations, or as a potential alternative genetic test when other methods are unavailable or cost-prohibitive.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Up to Him

The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.

Study of Racism in Academic Research

According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.

Kodak Loan on Pause

NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.

Cell Studies on Blood Immune Features in Severe COVID-19 Cases, Alzheimer's Spatial Transcriptomes

In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.

Aug
18
Featured Webinar

COVID-19 Wastewater-Based Epidemiology: Methods and Insights for SARS-CoV-2 Community Surveillance

Sponsored by
Bio-Rad

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Aug
19
Featured Webinar

Case Study: An IVD Manufacturer’s Experience Building a Complete Sample-to-Result Workflow

Sponsored by
UgenTec

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.

Aug
24
Featured Webinar

Utility of Novel RNA-Based Tools in Oncology Drug Development

Sponsored by
Genecentric

This webinar, Part 1 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss how gene expression signatures can accelerate (and rehabilitate) drug programs, define targeted patient populations, expand drug indications, and improve clinical success.

Aug
25
Featured Webinar

Liquid Biopsy-based Molecular Risk Stratification of ALK-mutated Lung Cancer Patients

Sponsored by
Roche

Non-small cell lung cancer (NSCLC) patients with ALK rearrangements are treated with tyrosine kinase inhibitors (TKIs), which often leads to prolonged overall survival. However, treatment resistance will almost inevitably occur, and the disease remains incurable.

What's Popular?

In PCR

  1. T2 Biosystems Q2 Revenues Up 41 Percent, Beat Estimates

  2. Ender Diagnostics Receives CE Mark for SARS-CoV-2 PCR Test

  3. Solaris Diagnostics, Alpha Genomix Coronavirus Tests Get FDA Emergency Use Authorization

  4. FDA Grants Emergency Use Authorization for George Washington University Coronavirus PCR Test

  5. SARS-CoV-2 Study Documents Viral Dynamics in Young Adults With or Without Symptoms

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.